Chemaphor Inc. Raises $192,000 in Private Placement
2010年11月26日 - 10:00PM
Marketwired
Chemaphor Inc. (TSX VENTURE: CFR), today announced that it has
issued a total of 1,920,000 common shares and 810,000 common share
purchase warrants for gross proceeds of $192,000 through a private
placement.
This private placement involved the sale of units, each
comprised of one common share and one half of a common share
purchase warrant, for a unit price of $0.10. Each whole warrant
entitles the holder to acquire one common share of Chemaphor at an
additional purchase price of $0.10 per share for two years from
closing. The warrants are subject to an accelerated expiry if, at
any time after an initial 4 month hold period expires, the closing
price of Chemaphor's common shares on the TSX Venture Exchange
exceeds $0.20 for any 20 consecutive trading days, in which event
the holder will be given notice that the warrants will expire 30
days following the date of such notice. The warrants may be
exercised by the holder during the 30-day period between the notice
and the expiration of the warrants.
In connection with the private placement Macquarie Private
Wealth and Bloom Burton & Co. acted as agents/finders and as a
group received an aggregate of $19,200 in cash commission and
warrants to acquire 192,000 common shares. These warrants have the
same terms as the warrants issued to subscribers in the private
placement.
The net proceeds of the proposed offering will be used to fund
working capital and research and development expenditures and for
general corporate purposes.
The securities issued under this private placement are and will
be subject to restrictions on transfer, including a hold period
ending four months after issuance. The private placement remains
subject to TSX Venture Exchange approval. This news release does
not constitute an offer to sell or a solicitation of an offer to
buy any securities.
About Chemaphor
Chemaphor, a wellness company, is committed to developing and
delivering products to humans and animals to assist in optimizing
health and daily quality of life. Chemaphor is advancing product
candidates for the food animal market, companion animal market and
various, potential human applications. More information can be
found at www.chemaphor.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Contacts: Chemaphor Inc. Dr. Graham Burton 613-990-0969
Evolution Group Inc. Sylvain Archambault 1-866-703-4887
s.archambault@evolutiongrp.com
Chemaphor Inc. (TSXV:CFR)
過去 株価チャート
から 9 2024 まで 10 2024
Chemaphor Inc. (TSXV:CFR)
過去 株価チャート
から 10 2023 まで 10 2024
Real-Time news about Chemaphor Inc. (トロントベンチャー取引所): 0 recent articles
その他のChemaphor Inc.ニュース記事